Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Qualitest Pharmaceuticals, Inc., is recalling all lots of its Accusure Insulin Syringes, a type of syringe used to deliver insulin to patients with diabetes, because the syringes have been found to have needles that can detach from the syringe. When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection. The recall expands on an August recall of specific lots of Accusure Insulin Syringes for the same detaching needle issue, to cover all lots of Accusure Insulin Syringes.

Read the rest of this entry »

The Food and Drug Administration (FDA) has issued a recall of some ACCU-CHEK Sprint insulin pumps manufactured by Disetronic Medical Systems Inc., to customers, distributors and health care professionals. The pumps may have a defect in the “up” and/or “down” buttons, which may present as an intermittent or complete loss of function of the buttons. If the buttons do not function, users may not be able to change any programmed setting on the pump. In the event of a failure, the pump may not respond with a vibration or acoustic confirmation signal to a button press and the display will remain unchanged.

Read the rest of this entry »

The U.S. Food and Drug Administration has issued an alert for healthcare professionals and patients that a lot of ReliOn insulin syringes sold at Wal-Mart and Sam’s Club’s may be dangerously mislabeled. The manufacturer of the syringes, Tyco Healthcare Group LP, has voluntarily recalled the needles.

Diabetes patients who use the recalled syringes may inadvertently receive an overdose of up to 2.5 times the intended dose. Possible complications could include hypoglycemia and other serious side effects and death.

Read the rest of this entry »